These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4687386)

  • 1. Carbamoylation of proteins following administration to rats of carbamoyl phosphate and cyanate and effects on memory.
    Crist RD; Grisolia S; Bettis CJ; Grisolia J
    Eur J Biochem; 1973 Jan; 32(1):109-16. PubMed ID: 4687386
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 3. Some comparative aspects of carbamylation of human blood and of hemoglobin with cyanate and carbamyl phosphate.
    Carreras-Barnes J; Diederich DA; Grisolia S
    Eur J Biochem; 1972 May; 27(1):103-8. PubMed ID: 5049047
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effects of carbamyl phosphate and sodium cyanate on protein synthesis and glutathione concentration in human sickle cell and rabbit reticulocytes.
    Freedman ML; Forte FJ; Roseman J
    J Pharmacol Exp Ther; 1975 Nov; 195(2):340-6. PubMed ID: 1185603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of cyanate in sickle cell anemia.
    Harkness DR; Roth S
    Prog Hematol; 1975; 9():157-84. PubMed ID: 766071
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium cyanate as a potential treatment for sickle-cell disease.
    Gillette PN; Peterson CM; Lu YS; Cerami A
    N Engl J Med; 1974 Mar; 290(12):654-60. PubMed ID: 4813727
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of cyanate. I. General effects on experimental animals.
    Cerami A; Allen TA; Graziano JH; DeFuria FG; Manning JM; Gillette PN
    J Pharmacol Exp Ther; 1973 Jun; 185(3):653-66. PubMed ID: 4197279
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of cyanate, carbamyl phosphate and growth on the glutamine dependent carbamyl phosphate synthetase from rat spleen and brain.
    Forman HJ; Grisolia S
    Physiol Chem Phys; 1974; 6(3):213-23. PubMed ID: 4500013
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical use of cyanate in sickling.
    Ranney HM
    N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacology of cyanate with a summary of its initial usage in sickle cell disease.
    Gillette PN; Lu YS; Peterson CM
    Prog Hematol; 1973; 8():181-90. PubMed ID: 4788375
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of the development of cyanate as a drug in the treatment of sickle cell anemia.
    Cerami A
    Ann N Y Acad Sci; 1974 Nov; 241(0):538-44. PubMed ID: 4611307
    [No Abstract]   [Full Text] [Related]  

  • 12. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of sickle cell disease: an approach with sodium cyanate.
    Peterson CM; Cerami A
    Semin Hematol; 1974 Oct; 11(4):569-76. PubMed ID: 4213637
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration of tyrosine aminotransferase multiple form patterns by antisickling agents and a decomposition product of antitumor agents.
    Johnson RW; Grossman A
    Biochem Biophys Res Commun; 1974 Aug; 59(4):1242-9. PubMed ID: 4153273
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo.
    Njikam N; Jones WM; Nigen AM; Gillette PN; Williams RC; Manning JM
    J Biol Chem; 1973 Dec; 248(23):8052-6. PubMed ID: 4752945
    [No Abstract]   [Full Text] [Related]  

  • 17. Reticulocyte survival in sickle cell anemia: effect of cyanate.
    Alter BP; Kan YW; Nathan DG
    Blood; 1972 Nov; 40(5):733-9. PubMed ID: 5078929
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbamoylation of amino acids and proteins in uremia.
    Kraus LM; Kraus AP
    Kidney Int Suppl; 2001 Feb; 78():S102-7. PubMed ID: 11168993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of cyanate. 3. Effects on the central nervous system.
    Leong JK; Grady RW; Herbert J; Graziano JH; Cerami A; Judge M; Quartermain D
    J Pharmacol Exp Ther; 1974 Oct; 191(1):60-7. PubMed ID: 4422034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.